TD Waterhouse Canada Inc. Sells 133,663 Shares of GE HealthCare Technologies Inc. $GEHC

TD Waterhouse Canada Inc. lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 26.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 368,982 shares of the company’s stock after selling 133,663 shares during the quarter. TD Waterhouse Canada Inc. owned approximately 0.08% of GE HealthCare Technologies worth $27,883,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock valued at $3,859,622,000 after purchasing an additional 703,903 shares in the last quarter. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares during the period. State Street Corp boosted its position in GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after acquiring an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after acquiring an additional 231,302 shares during the period. Finally, Norges Bank purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $468,120,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $79.26 on Thursday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The stock has a market cap of $36.10 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 2.43 and a beta of 1.08. The business has a 50-day simple moving average of $82.50 and a two-hundred day simple moving average of $77.31. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s revenue was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $1.14 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. Barclays began coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price target on the stock. Citigroup increased their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. BTIG Research reaffirmed a “buy” rating and set a $87.00 target price on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Finally, Stifel Nicolaus upped their price target on GE HealthCare Technologies from $90.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $89.83.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.